HIPC Data Coordinating Center
Funded at La Jolla Institute for Immunology · NIH-11591347 · Data updated 2026-11-12
A coordinated center to share and standardize immune-system data from many studies so researchers can learn more quickly about human immune responses.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | La Jolla Institute for Immunology NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | April 13, 2022 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $470,297 |
| NIH project number | 3U01AI167892-05S2 |
| Project ID | NIH-11591347 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians studying human immune responses and related diseases could benefit from improved data resources.
✕Less likely to help
Patients will not directly participate in this grant, and there is no single patient intervention.
What this research studies
The grant funds a coordinating center that will connect multiple HIPC centers, standardize data, and provide tools and a portal so scientists can access and reuse immune data. It aims to speed data sharing, enable cross-center analyses, and support administration for the network. This should help patients indirectly by accelerating discoveries about how the human immune system works in health and disease. The project builds on existing immune data portals and emphasizes collaboration, data standards, and broad accessibility.
Why it matters
Potential benefit: Faster, more reliable immune research could lead to new insights and therapies for immune-related diseases.
Where this research is happening
-
La Jolla Institute for Immunology
La Jolla, United States Active
Researchers
- Principal investigator: Peters, Bjoern — La Jolla Institute for Immunology
- Study coordinator: Peters, Bjoern
Related research
Other NIH-funded projects on the same topics.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Role of MAIT Cells in Primary Biliary Cholangitis (PBC)
This grant investigates how MAIT immune cells contribute to the autoimmune liver disease PBC and what that means for future therapies.
-
Dietary nudges that shape gut and liver immune guardians
A research project will explore how what you eat affects a special group of immune cells in the gut and liver that protect you from infections and cancer.
-
Cancer Epitope Database and Analysis Resource for Precision Oncology
A cancer-epitope database and analysis tools to help doctors and patients by advancing personalized cancer diagnostics and vaccines.
-
TET-DNMT-ASXL1-OGT axis and clonal hematopoiesis in cancer and aging
A long-running NIH project is exploring how specific gene mutations alter blood cell development and contribute to cancer, aging, and inflammation in people.
-
Immune cell gene activity map across diverse ancestries
A large NIH project will build a reference map showing how genetic differences affect gene activity in immune cells from people of diverse ancestral backgrounds.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.